Clinical Trial Update: Metformin and Congenital Nephrogenic Diabetes Insipidus [Phase 1]

View source ↗

Summary

Phase 1 trial of metformin for nephrogenic diabetes insipidus led by Emory University has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrogenic Diabetes Insipidus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Emory University | Conditions: Diabetes Insipidus | Phase 1 | Status: TERMINATED